Treatment for Shingles (Herpes Zoster)
Start oral antiviral therapy with famciclovir 500 mg three times daily, valacyclovir 1000 mg three times daily, or acyclovir 800 mg five times daily for 7 days, initiated within 72 hours of rash onset for maximum benefit. 1, 2
First-Line Antiviral Options
All three oral antivirals are FDA-approved and equally effective for shingles treatment, but differ in dosing convenience 1, 2, 3:
- Famciclovir 500 mg orally every 8 hours (three times daily) for 7 days 1
- Valacyclovir 1000 mg orally three times daily for 7 days 2, 4
- Acyclovir 800 mg orally five times daily for 7 days 2, 3
Famciclovir and valacyclovir offer superior dosing convenience (three times daily) compared to acyclovir (five times daily), which improves adherence. 2, 3
Timing of Treatment Initiation
- Treatment must be started within 72 hours of rash onset for optimal efficacy 2, 3
- Antiviral therapy shortens viral shedding duration by 1-2 days and reduces acute pain intensity and duration 2
- Evidence suggests famciclovir provides superior acute pain relief compared to valacyclovir, particularly in patients ≥50 years old, with significant pain reduction by days 3-4 5
Impact on Postherpetic Neuralgia (PHN)
Famciclovir is the only oral antiviral proven to reduce the duration of postherpetic neuralgia 6:
- Famciclovir recipients lost PHN two times faster than placebo (P = 0.02 all patients; P = 0.004 patients ≥50 years) 6
- This translates to a 3.5-month reduction in median PHN duration for patients 50 years or older 6
- The median duration of PHN was reduced from 100 days to approximately 56 days in older patients 6
Special Populations and Situations
Severe Disease Requiring Hospitalization
- Acyclovir 5-10 mg/kg IV every 8 hours for 5-7 days or until clinical resolution 7
Immunocompromised Patients
- Higher doses may be required: acyclovir 400 mg orally three to five times daily until clinical resolution 8
- For severe cases: intravenous acyclovir 5 mg/kg every 8 hours 8
- If lesions persist during treatment, suspect acyclovir resistance and consider foscarnet 40 mg/kg IV every 8 hours 9, 8
Renal Impairment
- Dose adjustment is mandatory based on creatinine clearance to prevent acute renal failure 1
- Acute renal failure may occur in patients with underlying renal disease receiving higher than recommended doses 1
Patients Who May Not Require Treatment
- Mild cases in younger, healthy individuals often do not require antiviral treatment 2
- However, given the proven benefit in reducing PHN duration, treatment should be strongly considered for all patients ≥50 years old 6
Important Contraindications and Warnings
- Do not use topical acyclovir—it is substantially less effective than oral therapy 9, 7
- Famciclovir is contraindicated in patients with known hypersensitivity to the product, its components, or penciclovir cream 1
- Avoid valacyclovir 8 grams per day in immunocompromised patients due to risk of hemolytic uremic syndrome/thrombotic thrombocytopenic purpura 9
Safety Profile
- All three oral antivirals are generally well tolerated with minimal adverse events 10
- Most common adverse events: headache and nausea (occurring in <10% of patients) 10, 1
- Antiviral resistance remains rare (<0.5%) in immunocompetent patients 10
- Probenecid may increase penciclovir levels; monitor for toxicity if co-administered 1
Pain Management Considerations
- Pain in shingles may have burning, lancinating, or allodynic qualities and typically lasts 2-8 weeks 2
- Pain treatment should be tailored to the type and intensity experienced 2
- Famciclovir demonstrates significantly earlier pain reduction (days 3-4) compared to valacyclovir, particularly beneficial for patients with moderate symptoms 5